Skip Navigation
Skip to contents



10 results

Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer

Kim KH, Song SY, Lim KH, Han SS, Kim SH, Cho JH, Park CW, Lee S, Lee HY

  • Cancer Res Treat.
  • 2013 Mar;45(1):74-77.
Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show...
A Case Report of Paraneoplastic Pemphigus Associated with Esophageal Squamous Cell Carcinoma

Cho JH, Kim NJ, Ko SM, Kim C, Ahn HK, Yun J, Park YH

  • Cancer Res Treat.
  • 2013 Mar;45(1):70-73.
Paraneoplastic pemphigus is an autoimmune blistering and erosive mucocutaneous syndrome associated with underlying neoplasm. It is primarily associated with lymphoproliferative disorders, and uncommonly with malignancies of epithelial origin. We report...
ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma

Park KW, Jung ES, Kim DG, Yoo YK, Hong TH, Lee IS, Koh YH, Kim JH, Lee MA

  • Cancer Res Treat.
  • 2013 Mar;45(1):63-69.
PURPOSE: There are three types of bile duct cancer, intrahepatic cholangiocarcinoma (ICC), hilar cholangiocarcinoma (HC), and extrahepatic cholangiocarcinoma (EHC). Despite different clinical presentation, the same protocol has been used in...
Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy

Kim ST, Park KH, Kim JS, Shin SW, Kim YH

  • Cancer Res Treat.
  • 2013 Mar;45(1):55-62.
PURPOSE: Activating mutation of the KRAS oncogene is an established negative predictor for anti-epidermal growth factor receptor (anti-EGFR) therapies in metastatic colorectal cancer (CRC). However, KRAS mutation as a prognostic...
Prognostic Value of Different Patterns of Squamous Cell Carcinoma Antigen Level for the Recurrent Cervical Cancer

Jeong BK, Huh SJ, Choi DH, Park W, Bae DS, Kim BG

  • Cancer Res Treat.
  • 2013 Mar;45(1):48-54.
PURPOSE: In some unusual cases, in patients with cervical cancer, an elevation of squamous cell carcinoma antigen (SCC-Ag) was not observed at diagnosis but was observed on recurrence, or vice...
Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer

Lee HJ, Kim HS, Park NH, Chung HH, Kim JW, Song YS

  • Cancer Res Treat.
  • 2013 Mar;45(1):40-47.
PURPOSE: The purpose of this study is to evaluate the efficacy and toxicity of oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX-4) chemotherapy in heavily pretreated patients with recurrent epithelial ovarian cancer (EOC). MATERIALS...
Adjuvant Postoperative Radiotherapy with or without Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Importance of Patient Selection for the Postoperative Chemoradiotherapy

Lee JH, Song JH, Lee SN, Kang JH, Kim MS, Sun DI, Kim YS

  • Cancer Res Treat.
  • 2013 Mar;45(1):31-39.
PURPOSE: We wanted to evaluate the role of postoperative chemoradiotherapy (CRT) for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). MATERIALS AND METHODS: From March 1993...
Response Evaluation after Neoadjuvant Chemoradiation by Positron Emission Tomography-Computed Tomography for Esophageal Squamous Cell Carcinoma

Park JS, Choi JY, Moon SH, Ahn YC, Lee J, Kim D, Kim K, Shim YM

  • Cancer Res Treat.
  • 2013 Mar;45(1):22-30.
PURPOSE: Parameters of positron emission tomography-computed tomography (PET-CT) were compared with the results of histopathologic examination in order to determine which can provide an objective indication of response after neoadjuvant...
Prediction of Cancer Incidence and Mortality in Korea, 2013

Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS

  • Cancer Res Treat.
  • 2013 Mar;45(1):15-21.
PURPOSE: To estimate the current cancer burden in Korea, cancer incidence and mortality rates were projected for the year 2013. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2010 were...
Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010

Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS

  • Cancer Res Treat.
  • 2013 Mar;45(1):1-14.
PURPOSE: This article gives an overview of nationwide cancer statistics, including incidence, mortality, survival and prevalence, and their trends in Korea based on 2010 cancer incidence data. MATERIALS AND METHODS: Incidence...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: